(303 days)
No
The summary does not mention AI, ML, or any related concepts in the device description, intended use, or performance studies.
Yes
The device is indicated for the ablation (coagulation) of soft tissue, including non-resectable liver tumors, which is a therapeutic intervention designed to treat a medical condition.
No
The device is described as an "Ablation System" used for the "ablation (coagulation) of soft tissue," which is a treatment rather than a diagnostic function.
No
The device description explicitly states it is a "self-contained stand-alone system of hardware and software" and lists hardware components like a cart, Power Distribution Module, and microwave ablation probes.
Based on the provided information, the NEUWAVE™ Microwave Ablation System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for the ablation (coagulation) of soft tissue within the body (percutaneous, open surgical, laparoscopic). This is a therapeutic procedure performed directly on the patient's tissue.
- Device Description: The device delivers microwave energy to heat and destroy tissue within the body.
- Lack of In Vitro Activity: IVD devices are designed to examine specimens outside of the body (in vitro) to provide information for diagnosis, monitoring, or screening. The NEUWAVE system does not perform any such analysis on specimens.
The NEUWAVE system is a therapeutic device used for tissue destruction within the patient's body, not for diagnostic testing of samples.
N/A
Intended Use / Indications for Use
The NEUWAVE™ Microwave Ablation System and Accessories are indicated for the ablation (coagulation) of soft tissue in percutaneous, open surgical and in conjunction with laparoscopic surgical settings, including the partial or complete ablation of non-resectable liver tumors.
The NEUWAVE Microwave Ablation System is not indicated for use in cardiac procedures.
Product codes (comma separated list FDA assigned to the subject device)
NEY
Device Description
The NEUWAVE Microwave Ablation System is a self-contained stand-alone system of hardware and software designed for the ablation of soft tissue, including the partial or complete ablation of non-resectable liver tumors, which applies microwave energy to produce tissue heating effects generating tissue necrosis.
The system consists of three major components (1) a cart which contains the components necessary to deliver microwave power to the microwave ablation probes, monitor and control system functions, a graphical user interface for the user to interact with the system and a CO2 based cooling system, (2) a Power Distribution Module (PDM), (3) a range of microwave ablation probe accessories for energy delivery.
The cart has a single 2.45 GHz signal microwave source with three 140W microwave power amplifiers, a touch-screen graphical user interface, and a CO2 based cooling system for limiting the temperature of the ablation probe, handle and cable.
The CO2 cooling system enables the Tissu-Loc function, which involves formation of an ice ball to adhere the probe in place prior to starting ablation therapy. This helps eliminate probe migration during imaging (CT scans, ultrasounds, etc.) and additional probe placement. The cooling system is responsible for controlling the pressure of the incoming CO2 gas from two E-sized CO2 cylinders located on the back of the cart.
The graphical user interface allows the user to set, adjust and activate the power setting per probe, time setting for each probe, ability to synchronize ablation initiation on probes, ablation activation, cauterization activation, audible volume, probe temperature, and Tissu-Loc function.
Ablation Confirmation software (previously cleared under K192427) is available as an optional feature for the NEUWAVE Microwave Ablation System. When this option is supplied, a second monitor is provided with the cart which hosts the Ablation Confirmation graphical user interface.
Up to three (3) NEUWAVE Ablation Probes can connect to the PDM at once and the PDM allows power to be transferred from the system cart to the ablation probes.
The microwave ablation probes are accessories which transfer microwave energy from the system cart to the target tissue to create regions of thermal necrosis. Each probe contains thermocouples that monitor the temperature of the probes can be used for Surgical Mode or Ablation Mode with various limits of maximum selectable power based on the probe type.
NEUWAVE LK, and NEUWAVE PR ablation probes are available in either 17- gauge or 15gauge cannulas and are available in 15 cm and 20 cm lengths. These probes have a cable length of 1.4m.
NEUWAVE LN ablation probes are available only in 17-gauge cannulas and are available in 15 cm and 20 cm lengths. These probes have a cable length of 1.4m.
NEUWAVE SR ablation probes have a 13-gauge cannula and are available in a 25 cm length only. NEUWAVE SR probes have a cable length of 1.4m.
NEUWAVE Surgical PR Ablation Probes have a 15-gauge cannula and a 15 cm length. These probes have a 2.9m cable length and the probe tip has a non-stick coating that facilitates repeat ablations/Planar Coagulation and helps prevent ablated tissue from adhering to the tip of the probe.
The antenna of the NEUWAVE PR probe family is designed to limit the length of the ablation for instances when a shorter ablation zone is desired. NEUWAVE PR Probes were developed to provide physicians with an additional ablation probe option with a different ablation burn pattern compared with NEUWAVE LK/LN/SR probes. The NEUWAVE PR probes are designed to produce ablations that quickly encompass the tip of the probe while limiting the overall length of the ablation compared with other NEUWAVE ablation probes.
The selection of available ablation probes provides physicians with the opportunity to select the length, stiffness, burn pattern and number of probes to use to create a wide variety of ablation zone sizes and shapes.
A dual probe clip is a single use sterile surgical accessory designed to hold two microwave ablation probes (15 gauge or 17 gauge) together in a parallel configuration at a fixed distance apart to facilitate planar coagulation of soft tissue during a surgical resection using Surgical Mode.
An optional footswitch accessory can be connected to the system to control power delivery in Surgical Mode.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissue, liver
Indicated Patient Age Range
Not Found
Intended User / Care Setting
percutaneous, open surgical and in conjunction with laparoscopic surgical settings
The system is designed for facility use and should only be used under the orders of a clinician.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical testing was performed as Design Verification testing to assure that the modified NEUWAVE Microwave Ablation System and accessories with the NEUWAVE Surgical PR probe meets its design and performance specifications. This testing included:
- Probe Physical Attribute Testing
- Ablation Probe Characterization Testing in ex-vivo liver (bovine), lung (bovine) and kidney (porcine) tissue
- Comparative Ablation Performance Testing per FDA Guidance of subject PRS15 probe versus predicate PR15XT probe per in ex-vivo liver, kidney and muscle, including histological evaluations to support substantial equivalence
- Probe tissue adhesion testing
- Probe biocompatibility testing per ISO 10993 Series and FDA Guidance
- System Electrical Safety Testing per IEC 60601-1, Edition 3.1
- System EMC Testing per IEC 60601-1-2, 4th Edition
- System Testing to IEC 60601-2-2
- System Testing to IEC 60601-2-6
All testing passed, and all acceptance criteria were met.
Software verification and validation testing was conducted and documentation was provided within the submission as recommended by Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, dated May 11, 2005.
No animal data was relied upon and no clinical data was generated.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
November 13, 2020
NeuWave Medical, Inc. Dan Kosednar Regulatory Affairs Consultant 3529 Anderson Street Madison, Wisconsin 53704
Re: K200081
Trade/Device Name: NEUWAVE Microwave Ablation System and Accessories Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical Cutting and Coagulation Device and Accessories Regulatory Class: Class II Product Code: NEY Dated: October 13, 2020 Received: October 14, 2020
Dear Dan Kosednar:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
K200081
Device Name NEUWAVE Microwave Ablation System and Accessories
Indications for Use (Describe)
The NEUWAVE™ Microwave Ablation System and Accessories are indicated for the ablation (coagulation) of soft tissue in percutaneous, open surgical and in conjunction with laparoscopic surgical settings, including the partial or complete ablation of non-resectable liver tumors.
The NEUWAVE Microwave Ablation System is not indicated for use in cardiac procedures.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.
3
Image /page/3/Picture/1 description: The image shows the logo for NeuWave Medical. The logo consists of a green circle with a white wave-like design inside, followed by the text "NeuWave Medical" in a simple, sans-serif font. Below the company name, in smaller letters, it says "PART OF THE ETHICON FAMILY OF COMPANIES".
510(k) Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
| Date: | 11/12/2020 |
|---|---|
| Company: | NeuWave Medical Inc. |
| 3529 Anderson street | |
| Madison, WI 53704 |
FDA Establishment# 3008769756
| Contact Person: | Dan Kosednar, Consultant |
|---|---|
| dan.kosednar@neuwave.com | |
| Phone: 608-216-9902 | |
| Fax: 608-512-1509 | |
| Company Contact: | Neda Chini |
| Senior Regulatory Affairs Program Lead | |
| Phone: 949-789-8656 | |
| Email: nchini@its.jnj.com |
Device Name
| Proprietary Name: | NEUWAVE™ Microwave Ablation System and Accessories |
|---|---|
| Common Name: | System, Ablation, Microwave and Accessories |
| Classification Name: | Electrosurgical cutting and coagulation device and accessories |
| Device Class: | Class II |
| Product Code: | NEY |
| CFR Section: | 21 CFR 878.4440 |
4
Predicate Device
The NEUWAVE Microwave Ablation System and Accessories is substantially equivalent to the following currently marketed device:
- Predicate Device Certus 140 2.45 GHz Ablation System and Accessories cleared ● under K173756 on October 24, 2018.
- Reference Device CertuSurgon Surgical Tool cleared under K130399 on July 18th, ● 2013.
Indications for Use
The NEUWAVE™ Microwave Ablation System and Accessories are indicated for the ablation (coagulation) of soft tissue in percutaneous, open surgical and in conjunction with laparoscopic surgical settings, including the partial or complete ablation of non-resectable liver tumors.
The NEUWAVE Microwave Ablation System is not indicated for use in cardiac procedures.
There are 3 primary changes covered by this 510(k) submission:
A new Microwave Ablation Probe, the Surgical PR Probe (PRS15), available for use with 1. the NEUWAVE System.
Updates to the NEUWAVE System software to accommodate the new PRS15 probe and 2. to implement various enhancements to the user experience and correct minor software anomalies that do not impact safety or effectiveness.
- Several minor design changes implemented since K173756 which were evaluated per FDA Guidance Deciding When To Submit a 510(k) for a Change to an Existing Device, October, 2017 and it was determined to NOT require a 510(k) prior to marketing, including an updated Dual Probe Clip which now accommodates both 17-gauge and 15-gauge ablation probes.
No changes were made to the existing family of NEUWAVE Ablation Probes nor to any hardware aspects of the existing NEUWAVE system.
Device Description
The NEUWAVE Microwave Ablation System is a self-contained stand-alone system of hardware and software designed for the ablation of soft tissue, including the partial or complete ablation of non-resectable liver tumors, which applies microwave energy to produce tissue heating effects generating tissue necrosis.
The system consists of three major components (1) a cart which contains the components necessary to deliver microwave power to the microwave ablation probes, monitor and control system functions, a graphical user interface for the user to interact with the system and a CO2
5
based cooling system, (2) a Power Distribution Module (PDM), (3) a range of microwave ablation probe accessories for energy delivery.
The cart has a single 2.45 GHz signal microwave source with three 140W microwave power amplifiers, a touch-screen graphical user interface, and a CO2 based cooling system for limiting the temperature of the ablation probe, handle and cable.
The CO2 cooling system enables the Tissu-Loc function, which involves formation of an ice ball to adhere the probe in place prior to starting ablation therapy. This helps eliminate probe migration during imaging (CT scans, ultrasounds, etc.) and additional probe placement. The cooling system is responsible for controlling the pressure of the incoming CO2 gas from two E-sized CO2 cylinders located on the back of the cart.
The graphical user interface allows the user to set, adjust and activate the power setting per probe, time setting for each probe, ability to synchronize ablation initiation on probes, ablation activation, cauterization activation, audible volume, probe temperature, and Tissu-Loc function.
Ablation Confirmation software (previously cleared under K192427) is available as an optional feature for the NEUWAVE Microwave Ablation System. When this option is supplied, a second monitor is provided with the cart which hosts the Ablation Confirmation graphical user interface.
Up to three (3) NEUWAVE Ablation Probes can connect to the PDM at once and the PDM allows power to be transferred from the system cart to the ablation probes.
The microwave ablation probes are accessories which transfer microwave energy from the system cart to the target tissue to create regions of thermal necrosis. Each probe contains thermocouples that monitor the temperature of the probes can be used for Surgical Mode or Ablation Mode with various limits of maximum selectable power based on the probe type.
NEUWAVE LK, and NEUWAVE PR ablation probes are available in either 17- gauge or 15gauge cannulas and are available in 15 cm and 20 cm lengths. These probes have a cable length of 1.4m.
NEUWAVE LN ablation probes are available only in 17-gauge cannulas and are available in 15 cm and 20 cm lengths. These probes have a cable length of 1.4m.
NEUWAVE SR ablation probes have a 13-gauge cannula and are available in a 25 cm length only. NEUWAVE SR probes have a cable length of 1.4m.
NEUWAVE Surgical PR Ablation Probes have a 15-gauge cannula and a 15 cm length. These probes have a 2.9m cable length and the probe tip has a non-stick coating that facilitates repeat ablations/Planar Coagulation and helps prevent ablated tissue from adhering to the tip of the probe.
6
The antenna of the NEUWAVE PR probe family is designed to limit the length of the ablation for instances when a shorter ablation zone is desired. NEUWAVE PR Probes were developed to provide physicians with an additional ablation probe option with a different ablation burn pattern compared with NEUWAVE LK/LN/SR probes. The NEUWAVE PR probes are designed to produce ablations that quickly encompass the tip of the probe while limiting the overall length of the ablation compared with other NEUWAVE ablation probes.
The selection of available ablation probes provides physicians with the opportunity to select the length, stiffness, burn pattern and number of probes to use to create a wide variety of ablation zone sizes and shapes.
A dual probe clip is a single use sterile surgical accessory designed to hold two microwave ablation probes (15 gauge or 17 gauge) together in a parallel configuration at a fixed distance apart to facilitate planar coagulation of soft tissue during a surgical resection using Surgical Mode.
An optional footswitch accessory can be connected to the system to control power delivery in Surgical Mode.
Comparison of Intended Use and Indications for Use
The subject device differs from the predicate device by a minor modification to the Indications for Use to remove language deemed unnecessary as shown in the table below and the associated changes to the labeling.
| Predicate Device | Subject Device | |
|---|---|---|
| Device | ||
| Characteristics | NEUWAVE Microwave Ablation System | |
| and Accessories | ||
| (K173756) | NeuWave Microwave Ablation System | |
| and Accessories with Added NEUWAVE | ||
| Surgical PR Probe | ||
| Intended Use | To thermally ablate soft tissue using | |
| microwave energy | Same | |
| Indications for | ||
| Use | The NeuWave Medical Certus 140TM 2.45 | |
| GHz Ablation System and Accessories are | ||
| indicated for the ablation (coagulation) of | ||
| soft tissue in percutaneous, open surgical | ||
| and in conjunction with laparoscopic | ||
| surgical settings, including the partial or | ||
| complete ablation of non-resectable liver | ||
| tumors. |
The Certus 140TM 2.45 GHz Ablation
System is not indicated for use in cardiac
procedures.
The system is designed for facility use and
should only be used under the orders of a
clinician. | The NEUWAVETM Microwave Ablation
System and Accessories are indicated for
the ablation (coagulation) of soft tissue in
percutaneous, open surgical and in
conjunction with laparoscopic surgical
settings, including the partial or complete
ablation of non-resectable liver tumors.
The NEUWAVE Microwave Ablation
System is not indicated for use in cardiac
procedures. |
7
Comparison of Technological Characteristics with Predicate Device
The subject and the predicate devices are similar in terms of technological characteristics as microwave devices used to ablate soft tissue, including the partial or complete ablation of nonresectable liver tumors.
The subject device includes a new ablation probe, the NEUWAVE Surgical PR (PRS15) probe which uses the identical cannula, antenna design and ablation pattern as the predicate NEUWAVE PR (15cm, 15 gauge) probe (marketed as the PR15XT). The PRS15 probe has a longer (2.9 m) and more flexible cable than the predicate, but these components are identical to the cable used on the reference CertuSurgST. The longer, more flexible cable allows the user greater flexibility in the placement of the microwave ablation system cart relative to the patient bed and helps prevents cable management challenges. The PRS15 probe also has the identical non-stick material coating on the probe tip as the reference CertuSurg(". The non-stick coating facilitates repeat ablations/Planar Coagulation and helps prevent ablated tissue from adhering to the tip of the probe.
The maximum Ablation Mode power (80W) for use with PRS15 probe was selected to deliver equivalent power at the probe emitting point and result in equivalent ablation zone performance compared to the predicate PR15XT maximum power (65W in Ablation Mode). The higher limits for maximum power are required to compensate for the loss of microwave power in the longer cable length (i.e. microwave power dissipates as a function of length traveled). No changes were made to the maximum power settings for existing NEUWAVE ablation probes.
Minor software updates to the system were incorporated to modify the graphical user interface to include the PRS15 probe and implement enhancements for a visual ex-vivo ablation results guide on the touch screen. This guide provides ex-vivo ablation results when using probes at various power and time settings.
| Predicate Device | Subject Device | ||
|---|---|---|---|
| Feature/Specification | NeuWave Microwave | ||
| Ablation System and | |||
| Accessories (K173756) | NeuWave Microwave | ||
| Ablation System and | |||
| Accessories with Added | |||
| PRS15 | |||
| Software Version | V3.0.X software | V3.1.X software | |
| Probe Applications | Percutaneous, open surgical | ||
| and in conjunction with | |||
| laparoscopic surgical settings. | |||
| The CertuSurgGT surgical tool | |||
| is for open surgical procedures | |||
| only. | Same | ||
| User Interface Modes | Surgical and Ablation Mode | Same | |
| Predicate Device | Subject Device | ||
| Feature/Specification | NeuWave Microwave | ||
| Ablation System and | |||
| Accessories (K173756) | NeuWave Microwave | ||
| Ablation System and | |||
| Accessories with Added | |||
| PRS15 | |||
| Power Delivery Initiation Method | User Interface or Footswitch | ||
| (Footswitch available in | |||
| Surgical Mode only) | Same | ||
| Probe dimensions | |||
| NEUWAVE LK Probe | Diameter: 15 gauge, Length: | ||
| 15 cm and 20 cm | Same | ||
| Diameter: 17 gauge, Length: | |||
| 15 cm and 20 cm | |||
| NEUWAVE LN Probe | Diameter: 17 gauge, Length: | ||
| 15 cm and 20 cm | Same | ||
| NEUWAVE SR Probe | Diameter: 13 gauge, Length: | ||
| 25 cm | Same | ||
| NEUWAVE PR Probe | Diameter: 15 gauge, Length: | ||
| 15 cm and 20 cm | Same | ||
| Diameter: 17 gauge, Length: | |||
| 15 cm and 20 cm | |||
| NEUWAVE Surgical PR Probe | N/A | Diameter: 15 gauge, Length: | |
| 15 cm | |||
| Generator Maximum Output Power | |||
| NEUWAVE LK Probe | Ablation Mode and Surgical | ||
| Mode: Single Probe is 140W, | |||
| Two Probes is 95W, Three | Same | ||
| NEUWAVE LN Probe | Probes is 65W | ||
| NEUWAVE SR Probe | |||
| NEUWAVE PR Probe | Ablation Mode: Single Probe | ||
| is 65W, Two Probes is 65W, | |||
| Three Probes is 65W | |||
| Surgical Mode: Single Probe | |||
| is 95W, Two Probes is 95W, | |||
| Three Probes is 65W | Same | ||
| NEUWAVE Surgical PR Probe | N/A | Ablation Mode: Single Probe | |
| is 80W, Two Probes is 80W, | |||
| Three Probes is 80W |
Surgical Mode: Single Probe
is 110W, Two Probes is
110W, Three Probes is 80W | |
| | Predicate Device | Subject Device | |
| Feature/Specification | NeuWave Microwave
Ablation System and
Accessories (K173756) | NeuWave Microwave
Ablation System and
Accessories with Added
PRS15 | |
| Antenna Design | Triaxial Antenna for
NEUWAVE LK Probe,
NEUWAVE LN Probe and
NEUWAVE SR Probe | Same | |
| | Modified Triaxial Antenna for
NEUWAVE PR Probe | Same for NEUWAVE PR
Probe and NEUWAVE
Surgical PR Probe | |
| Settable Parameters | | | |
| Power | NEUWAVE LK Probe,
NEUWAVE LN Probe and
NEUWAVE SR Probe: 20W-
140W in 5W increments | Same | |
| | NEUWAVE PR Probe: 20W-
95W in 5 W increments
(Ablation Mode maximum is
65W) | Same | |
| | NEUWAVE Surgical PR
Probes: N/A | NEUWAVE Surgical PR
Probes: 20W-110W in 5 W
increments
(Ablation Mode maximum is
80W) | |
| Target Ablation Time | Up to 10 minutes as limited by
software. User may ablate for
additional time after 10
minutes of ablation
completion. | Same | |
| Planar Coagulation Time | 5 seconds - 1 Minute | Same | |
| Accessories | Dual Probe Clip
CT Table Mounting Adapter
for PDM
Surgical Table Mounting
Adapter for PDM
Foot switch (Locking USB or
Standard USB) | Dual Probe Clip updated to
accommodate both 17-gauge
and 15-gauge probes. Other
accessories remain unchanged. | |
8
9
10
| Feature/Specification | Reference Device | Subject Device |
|---|---|---|
| NeuWave Microwave | ||
| CertuSurgGT Ablation Tool | ||
| (K130399) | NeuWave Microwave Ablation | |
| System and Accessories with | ||
| Added NEUWAVE Surgical | ||
| PR Probe | ||
| Probe Cable Length | 2.9m | Same |
| Non-Stick Coating on Probe Tip | Non-Stick Coating applied to | |
| facilitate multiple | ||
| ablations/planar coagulation to | ||
| help prevent ablated tissue from | ||
| adhering to probe tip | Same |
Sterilization:
NeuWave Microwave Ablation Probes are provided to customers sterile. The probes are packed in thermoform plastic trays containing a single probe and sealed with a Tyvek lid prior to sterilization. The product is over-packed in an e-flute box to further protect the sterile barrier.
The validated sterilization method for NEUWAVE Ablation Probes is Ethylene Oxide. Device specific methods were developed using the "overkill" approach and validated per ISO 11135:2014. Results demonstrated a Sterility Assurance Level (SAL) of 106.
The Dual Probe Clip (RCPK Probe Surgical Clip (DR-001193)) is sterilized via gamma radiation and was validated to have a minimum sterility assurance level of 10th Per ISO 11137-2 Method VDMax - Substantiation of 25kGy.
Shelf Life:
Accelerated aging tests were conducted to confirm the validity of the 48-month shelf life for ablation probes and 18 months for dual probe clips.
Biocompatibility:
The NEUWAVE Ablation Probes are classified as an External Communicating Device, Tissue/bone/dentin patient contact, with a contact duration of (